NumberAuthorsTitleJournalLink (if Available)
116Zeller MP, Barty R, Dunbar NM, Elahie A, Flanagan P, Garritsen H, Kutner JM, Pagano MB, Pogłód R, Rogers TS, Staves J, van Wordragen-Vlaswinkel M, Zwaginga JJ, Murphy MF, Heddle NM, Yazer MH, on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.An international investigation into AB plasma administration in hospitals: how many AB plasma units were infused? The HABSWIN study.Transfusion. 2017 DOI: 10.1111/trf.14368. [Epub ahead of print]
115Goldman M, Steele WR, di Angelantonio E, van den Hurk K, Vassallo RR, Germain M, O’Brien SFComparison of donor and general population demographics over time: a BEST Collaborative group studyTransfusion 2017 Oct;57(10):2469-2476
114Gorlin J, Kinney S, Fung MK ,Tinmouth A, for the BEST Collaborative.Prothrombin complex concentrate for emergent reversal of warfarin: an international survey of hospital protocols.Vox Sang. 2017 Aug;112(6):595-597. doi: 10.1111/vox.12539. Epub 2017 Jun 21.
113Dunbar NM, Yazer MH, On behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative and the STAT Study Investigators.Safety of the use of group A plasma in trauma: the STAT study.Transfusion. 2017 Jun 8. doi: 10.1111/trf.14139. [Epub ahead of print]
112Zeller MP, Barty R, Aandahl A, Apelseth TO, Callum J, Dunbar NM, Elahie A, Garritsen H, Hancock H, Kutner JM, Manukian B, Mizuta S, Okuda M, Pagano MB, Pogłód R, Rushford K, Selleng K, Sørensen CH, Sprogøe U, Staves J, Weiland T, Wendel S, Wood EM17, van de Watering L, van Wordragen-Vlaswinkel M, Ziman A, Jan Zwaginga J, Murphy MF, Heddle NM, Yazer MH; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. An international investigation into O red blood cell unit administration in hospitals: the GRoup O Utilization Patterns (GROUP) study.2017 Aug 25. doi: 10.1111/trf.14255. [Epub ahead of print]
111Liu S, de Castro LF, Jin P, Civini S, Ren J, Reems JA, Cancelas J, Nayak R, Shaw G, O'Brien T, McKenna DH, Armant M, Silberstein L, Gee AP, Hei DJ, Hematti P, Kuznetsov SA, Robey PG, Stroncek DF.Manufacturing Differences Affect Human Bone Marrow Stromal Cell Characteristics and Function: Comparison of Production Methods and Products from Multiple Centers.Sci Rep. 2017 Apr 27;7:46731. doi: 10.1038/srep46731.
110Worsham DN, Reems JA, Szczepiorkowski ZM, McKenna DH, Leemhuis T, Mathew AJ, Cancelas JA; Biomedical Excellence for Safer Transfusion (BEST) Collaborative Group.Clinical methods of cryopreservation for donor lymphocyte infusions vary in their ability to preserve functional T-cell subpopulations.Transfusion. 2017 Apr 28. doi: 10.1111/trf.14112. [Epub ahead of print]
109Yazer MH, Vassallo R, Delaney M, Germain M, Karafin MS, Sayers M, van de Watering L, Shaz BH on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Trends in age and red blood cell donation habits among several racial/ethnic minority groups in the United States.Transfusion. doi:10.1111/trf.14108. [Epub ahead of print.]
108Marks D, van der Meer PF, and on behalf of the Biomedical Excelllence for Safer Transfusion (BEST) Collaborative).Serum eye drops: a survey of international production methods.Vox Sang DOI:10.1111/vox.12502. [Epub ahead of print]
107Yazer MH, Lozano M, Fung M, Kutner J, Murphy MF, Oveland Apelseth T, Pogłód R, Selleng K, Tinmouth A, Wendel S, Yahalom V; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.An international survey on the role of the hospital transfusion committee.Transfusion. 2017 Feb 24. doi: 10.1111/trf.14033. [Epub ahead of print]
106Yazer MH, Delaney M, Germain M, Karafin MS, Sayers M, Vassallo R, Ziman 7, Shaz B; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Trends in US minority red blood cell unit donationsTransfusion. 2017 Feb 16. doi: 10.1111/trf.14039. [Epub ahead of print]
105Ruqayyah J. Almizraq, Qi Long Yi, Jason P. Acker, Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Impact of technical and assay variation on reporting of hemolysis in stored red blood cell products.Clin Chim Acta. 2017 Feb 20. Epub ahead of print.
104Germain M, Grégoire Y, Vassallo RR, Acker JP, Cardigan R, de Korte D, Irving D, Bégué S, and on behalf of the Biomedical Excellence for Safer Transfusions (BEST) collaborative.Quality control of apheresis platelets: a multi-center study to evaluate factors that can influence pH measurement.Vox Sang. DOI: 10.1111/vox.12505 [Epub ahead of print]
103van der Meer PF, Devine DV; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Alternatives in blood operations when choosing non-DEHP bags.Vox Sang. 2017 Jan 24. doi: 10.1111/vox.12479. [Epub ahead of print]
102Delaney M, Wikman A, van de Watering L, Schonewille H, Verdoes JP, Emery SP, Murphy MF, Staves J, Flach S, Arnold DM, Kaufman RM, Ziman A, Harm SK, Fung M, Eppes CF, Dunbar NM, Buser A, Meyer E, Savoia H, Abeysinghe P, Heddle N, Tinmouth A, Traore AN, Yazer MH, for the BEST Collaborative.Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) StudyTransfusion. 2017 Feb 5. doi: 10.1111/trf.13977. [Epub ahead of print]
101Yazer MH, Alcantara R, Beizai P, Draper NL, Harm SK, Kutner JM, Lin D, Poglod R, Rogers TS, Sørensen CH, Sprogøe U, Welbig J, Yuen J, Ziman A; Biomedical Excellence for Safer Transfusions (BEST) Collaborative.The Crossmatch/Issue Ratio: Use of a Novel Quality Indicator and Results of an International Survey on RBC Crossmatching and Issuing PracticesAm J Clin Pathol August 2016;146:238-243.
100Chapuy CI, Aguad MD, Nicholson RT, AuBuchon JP, Cohn CS, Delaney M, Fung MK, Unger M, Doshi P, Murphy MF Dumont LJ, Kaufman RM; DARA-DTT Study Group for the BEST Collaborative.International validation of a dithiothreitol (DTT)-based method to resolve the daratumumab interference with blood compatibility testing.Transfusion. 2016 Dec;56(12):2964-2972.
99Ziman A, Cohn C, Carey PM, Dunbar NM, Fung MK, Greinacher A, Stanworth S, Heddle NM, Delaney M and the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Warm Reactive (IgG) Autoantibodies and Laboratory Testing Best Practices: Review of the Literature and Survey of Current Practice.Transfusion. 2016 Dec 4. doi: 10.1111/trf.13903. [Epub ahead of print].
98Dunbar NM, Yazer MH, Bravo MD, Kamel HT, Gorlin J, Norris PJ, Williamson PC, Vassallo RR, On behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.An association between ABO group and HLA antibody detection.Transfusion. 2016 Nov 3. doi: 10.1111/trf.13901. [Epub ahead of print].
97Yazer MH, JacksonB, Beckman N, Chesneau S, Bowler P, Delaney M, Deveine D, Field S, Germain M, Murphy M, Sayers M, Shaz B, Shinar E, Takanashi M, Vassallo R, Wickenden C, Yahalom V, Land K, on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Changes in blood center red blood cell distributions in the era of patient blood management: the trends for collection (TFC) study.Transfusion doi:10.1111/trf.13696. [Epub ahead of print]
96Heddle NM, Wu C, Vassallo R, Carey P, Arnold D, Lozano M, Pavenski K, Sweeney S, Stanworth S, Liu Y, Traore A, Barty R, Tinmouth A.Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges.Transfusion 2011;51:2304-10.
95Murphy MF, Dumont LD, Greinacher A, for the BEST Collaborative.Correspondence: Interference of New Drugs with Compatibility Testing for Blood TransfusionN Engl J Med 2016; 375:295-296 July 21, 2016
94Delaney M, Wendel S, Bercovitz RS, Cid J, Cohn C, Dunbar N, Apelseth TO, Popovsky M, Stanworth SJ, Tinmouth A, Van De Watering L, Waters JH, Yazer M, Ziman A for the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Prevention, Diagnosis, and Treatment of Transfusion Reactions: Evidence-Based Review & Clinical Guideline.Lancet, 2016 April 12. DOI: [Epub ahead of print]
93Haspel RL, Lin Y, Mallick R, Tinmouth A, Cid J, Eichler H, Lozano M, van de Watering L, Fisher PB, Ali A, Parks E; BEST-TEST Investigators.Internal medicine resident knowledge of transfusion medicine: results from the BEST-TEST international education needs assessment.Transfusion. 2015 Jun;55(6):1355-61.
92Dzik WS, Ziman A, Cohen C, Pai M, Lozano M, Kaufman RM, Delaney M, Selleng K, Murphy MF, Hervig T, Yazer M; Biomedical Excellence for Safer Transfusion CollaborativeSurvival after ultramassive transfusion: a review of 1360 casesTransfusion. 2015 Oct 9. doi: 10.1111/trf.13370. [Epub ahead of print]
91Yulia Lin, Alan Tinmouth, Ranjeeta Mallick, Richard L. Haspel, andfor the BEST-TEST2 InvestigatorsBEST-TEST2: assessment of hematology trainee knowledge of transfusion medicine Transfusion. 2016 Feb;56(2):304-10. DOI: 10.1111/trf.13327
90Ralph Vassallo, Mindy Goldman, Marc Germain, Miguel Lozano for the BEST CollaborativePreoperative Autologous Blood Donation: Waning Indications in an Era of Improved Blood SafetyTransfus Med Rev. 2015 Oct;29(4):268-75.
89Nancy M Dunbar, Mark H. Yazer and on behalf of the Biomedical Excellence for Sater Transfusion (BEST) Collaborative.A possible new paradigm? A survey-based assessment of the use of thawed group A plasma for trauma resuscitation in the United States.Transfusion. 2016 Jan;56(1):125-9. doi: 10.1111/trf.13266
88Joan Cid, Miguel Lozano, Alyssa Ziman, Kamille A. West, Kerry L. O’Brien, Michael F. Murphy, Silvano Wendel, Alejandro Vázquez, Xavier Ortín, Tor A. Hervig, Meghan Delaney, Willy A. Flegel, and Mark H. Yazer on behalf of the Biomedical Excellence for Safer Transfusion collaborative.Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study.Br J Haematol. 2015 Feb;168(4):598-603. doi: 10.1111/bjh.13158. Epub 2014 Oct 4.
87Nawrot M, McKenna DH, Sumstad D, McMannis JD, Szczepiorkowski ZM, Belfield H, Grassman E, Temples T, Nielsen D, Yuan N, Wognum B, Reems JA.Interlaboratory assessment of a novel colony-forming unit assay: a multicenter study by the cellular team of Biomedical Excellence for Safer Transfusion (BEST) collaborative.Transfusion. 2011 Sep;51(9):2001-5.
86Richard L. HaspelVIDEO: A Validated Transfusion Medicine ExamTransfusion News. May 15, 2014
85Miguel Lozano, Anne Mahon, Pieter F. van der Meer, Simon Stanworth , Joan Cid, Dana Devine, Mark K Fung , Barbara de la Salle and Nancy M Heddle, on behalf of Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Counting platelets at transfusion threshold levels: impact on the decision to transfuse. A BEST Collaborative - UK NEQAS(H) International Exercise.Vox Sang. 2014 May;106(4):330-6.
84Richard L. Haspel, Yulia Lin, Patrick Fisher, Asma Ali, Eric Parks. From the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Development of a validated exam to assess physician transfusion medicine knowledge. Transfusion. 2014 May;54(5):1225-30. doi: 10.1111/trf.12425
83E. Levin, K. Serrano, D. V. Devine for the Biomedical Excellence for Safer Transfusion (BEST) CollaborativeStandardization of CD62P measurement: results of an international comparative study.Vox Sang. 2013 Jul;105(1):38-46.
82Walter H Dzik, Neil Beckman, Michael F Murphy, Peter Flanagan, Mark Fung, Marc Germain, Richard L Haspel, Miguel Lozano, Ronald Sacher, Zbigniew Szczepiorkowski, Silvano Wendel.Factors affecting RBC storage age at the time of transfusion.Transfusion. 2013 Dec;53(12):3110-9.
81Derwood Pamphilon; Eileen Selogie; David McKenna; Jose Cancelas-Peres; Zbigniew M. Szczepiorkowski; Ron Sacher; John McMannis, Hermann Eichler; Henk Garritsen; Minoko Takanashi; Leo van de Watering; David Stroncek; Jo-Anna Reems.Current practices and Prospects for Standardization of the Hematopoietic Colony-Forming-Unit (CFU) assay: A Report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Cytotherapy. 15(3):255-62, March 2013.
80John R. Hess for the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Scientific problems in the regulation of red blood cell products.Transfusion. 2012 Aug;52(8):1827-35.
79Meyer E, Delaney M, Lin Y, Morris A, Pavenski K, Tinmouth A, Murphy M, Slichter SJ, Heddle N, Dumont LJ.A reporting guideline for clinical platelet transfusion studies from the BEST Collaborative.Transfusion. 2013 Jun;53(6):1328-34.
78Nancy M. Heddle, Mark Fung, Tor Hervig, Zbigniew M. Szczepiorkowski, Lorella Torretta, Emmie Arnold, Shannon Lane, Michael F. Murphy, for the BEST Collaborative.Challenges and opportunities to prevent transfusion errors: a Qualitative Evaluation for Safer Transfusion (QUEST).Transfusion. 2012 Aug;52(8):1687-95.
77van der Meer PF, Karssing-van Leeuwen W, Kurtz J, Spengler HP, Blair A, Devine D, Harrison P, Lambrecht B, VandenBroeke T, de Wildt J, de Korte D; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.A flow cytometric method for platelet counting in platelet concentrates.Transfusion. 2012 Jan;52(1):173-80.
76E. Shinar, S. Etlin, O. Frenkel, V. Yahalom.The implementation of rapid cooling and overnight hold of whole blood at ambient temperature before processing into components in Israel.Transfusion 2011;51:58S-64S.
75R. Cardigan, P.F. Van der Meer, C. Pergande, P. Cookson, B. Baumann-Baretti, J.A. Cancelas, D. Devine, H. Gulliksson, R. Vassallo, J. de Wildt-Eggen.Coagulation factor content of plasma produced from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study.Transfusion 2011;51:50S-57S.
74Pieter F. van der Meer, Jose A. Cancelas, Ralph R. Vassallo, Neeta Rugg, Mindy Einarson, John R. Hess.Evaluation of the overnight hold of whole blood at room temperature, before component processing: platelets (PLTs) from PLT-rich plasma.Transfusion 2011;51:45S-49S.
73M.J. Dijkstra-Tiekstra, P.F. van der Meer, R. Cardigan, D. Devine, C. Prowse, P. Sandgren, J. de Wildt-Eggen, for the Biomedical Excellence for Safer Transfusion Collaborative.Platelet concentrates from fresh or overnight-stored blood, an international study.Transfusion 2011;51:38S-44S.
72John R. HessImproving the predictive value of red blood cell storage trials: lessons from the Biomedical Excellence for Safer Transfusion (BEST) Collaborative Trial 41.Transfusion 2011;51:34S-37S.
71Margaret F. Veale, Gerry Healey, Rosemary L. Sparrow.Effect of additive solutions on red blood cell (RBC) membrane properties of stored RBCs prepared from whole blood held for 24 hours at room temperature.Transfusion 2011;51:25S-33S.
70Pieter F. van der Meer, Jose A. Cancelas, Rebecca Cardigan, Dana V. Devine, Hans Gulliksson, Rosemary L. Sparrow, Ralph R. Vassallo, Janny de Wildt-Eggen, Bärbel Baumann-Baretti, John R. Hess, for the BEST Collaborative.Evaluation of overnight hold of whole blood at room temperature before component processing: effect of red blood cell (RBC) additive solutions on in vitro RBC measures.Transfusion 2011;51:15S-24S.
69Gary Moroff, James P. AuBuchon, Constance Pickard, Pamela H. Whitley, W. Andrew Heaton, Stein Holme.Evaluation of the properties of components prepared and stored after holding of whole blood units for 8 and 24 hours at ambient temperature.Transfusion 2011;51:7S-14S.
68R.N.I. PieterszStorage of whole blood for up to 24 hours at ambient temperature before component preparation: implementation in the Netherlands.Transfusion 2011;51:3S-6S.
67John R. HessThe overnight warm hold of whole blood before processing into blood components. Transfusion 2011;51:1S-2S.
66TRANSFUSION SUPPLEMENT JANUARY 2011.Special Issue: The Overnight Warm Hold of Whole Blood Before Processing into Components (Publications 67-76 inclusive)Transfusion. 2011;51(s1):1S-64S
65Leo van de Watering for the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Pitfalls in the Current Published Observational Literature on the Effects of RBC Storage.Transfusion.2011;51(8):1847-1854.
64Pamphilon D, Curnow E, Belfield H, Reems JA, McMannis J, Lecchi L, Szczepiorkowski Z, McKenna D.Storage Characteristics of Cord Blood Progenitor Cells: Report of a Multicentre Study by the Cellular Therapies Team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Transfusion.2011;51(6):1284-1290.
63Dumont LJ; Dumont DF; Unger ZM; Siegel A; Szczepiorkowski ZM; Corson JS; Jones MK; Christoffel T; Pellham E; Bailey SL; Slichter SJ.A Randomized Controlled Trial Comparing Autologous Radiolabeled In Vivo Platelet Recoveries And Survivals Of 7-Day Stored PRP And Buffy Coat Platelets From The Same Subjects - for the BEST Collaborative.Transfusion. 2011;51(6):1241-1248.
62Reikvam H, Prowse C, Roddie H, Heddle NM, Hervig T; BEST collaborative.A pilot study of the possibility and the feasibility of haemoglobin dosing with redblood cells transfusion.Vox Sang. 2010 Jul 1;99(1):71-6.
61Delaney M, Meyer E, Cserti-Gazdewich C, Haspel RL, Lin Y, Morris A, Pavenski K, Dzik WH, Murphy M, Slichter S, Wang G, Dumont LJ, Heddle N.A systematic assessment of the quality of reporting for platelet transfusion studies.Transfusion. 2010 Oct;50(10):2135-44.
60Pamphilon DH, Selogie E, Szczepiorkowski ZM; for the BEST Collaborative Cellular Therapies team.Transportation of cellular therapy products: report of a survey by the cellular therapies team of the Biomedical Excellence for Safer Transfusion (BEST) collaborative.Vox Sang. 2010 Aug 1;99(2):168-73.
59Lozano M, Heddle N, Williamson LM, Wang G, Aubuchon JP, Dumont LJ.Practices associated with ABO-incompatible platelet transfusions: a BEST Collaborative international survey.Transfusion 2010 August;50(8):1743-48.
58Hess JR, Sparrow RL, van der Meer P, Acker JP, Cardigan RA, Devine DV for the BEST Collaborative.Red cell hemolysis during blood bank storage: Using national quality management data to answer basic scientific questions.Transfusion 2009 Dec;49(12):2599-603.
57Nancy M Heddle, Richard J Cook, Alan Tinmouth, C. Tom Kouroukis, Tor Hervig, Ellen Klapper, Joseph M Brandwein, Zbigniew M Szczepiorkowski, James P AuBuchon, Rebecca L Barty, Ker-Ai Lee for the SToP Study Investigators of the BEST Collaborative.A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) tto patients with thrombocytopenia.Blood 2009, Feb;113:1564-1573.
56Pieter F. van der Meer, Margriet J. Dijkstra-Tiekstra, Anne Mahon, and Janny deWildt-Eggen for the BEST Collaborative.Counting platelets in platelet concentrates on hematology analyzers: a multicenter comparative study.Transfusion 2009, Jan, 49:81-90.
55JP AuBuchon, J de Wildt-Eggen, LJ Dumont.Reducing the variation in the variation in performance of antibody titrations.Vox Sanguinis 2008;95:57-65 and Arch Pathol Lab Med 2008;132:1194-1201. (joint publication).
54Walter Sunny Dzik, Neil Beckman, Kathleen Selleng, Nancy Heddle, Zbigniew Szczepiorkowski, Silvano Wendel, and Michael Murphy for the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Errors in patient specimen collection: application of statistical process control.Transfusion 2008 Oct;48(10):2143-51.
53LJ Dumont, JP AuBuchon for the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials.Transfusion 2008;48:1053-60.
51Brand A, Eichler H, Szczepiorkowski ZM, Hess JR, Kekomaki R, McKenna DH, Pamphilon D, Reems J, Sacher RA, Takahashi TA, van de Watering LM; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Viability does not necessarily reflect the hematopoietic progenitor cell potency of a cord blood unit: results of an interlaboratory exercise.Transfusion. 2008 Mar;48(3):546-9.
50Eichler H, Nguyen XD, Roelen D, Celluzzi CM, McKenna D, Pamphilon D, Blair A, Read EJ, Takahashi TA, Szczepiorkowski ZM; Biomedical Excellence for Safer Transfusion Collaborative.Multicenter study on in vitro characterization of dendritic cells.Cytotherapy. 2008;10(1):21-9.
49Murphy MF, Casbard AC, Ballard S, Shulman IA, Heddle N, Aubuchon JP, Wendel S, Thomson A, Hervig T, Downes K, Carey PM, Dzik WH; BEST Research Collaborative.Prevention of bedside errors in transfusion medicine (PROBE-TM) study: a cluster-randomized, matched-paired clinical areas trial of s simple intervention to reduce errors in the pretransfusion bedside check.Transfusion. 2007 May;47(5):771-80.
48Dumont LJ, Gulliksson H, van der Meet PF, Murphy S, Nixon JG, de Wildt-Eggen, J, VandenBroeke T, AuBuchon, JP.Interruption of Agitation of Platelet Concentrates - A Multi-center In-vitro Study by the BEST Collaborative on the Effects of Shipping Platelets.Transfusion 2007;47:1666-1673.
47Dumont, Larry J.Analysis and reporting of platelet kinetic studies.Transfusion 2006;46:67S-73S.
46The Biomedical Excellence for Safer Transfusion (BEST) Collaborative (2006).Platelet radiolabeling procedure.Transfusion 2006;46:59S.
45Taylor Harry L, Whitley Pamela, Heaton, Andrew.A historical perspective on platelet radiolabeling techniques.Transfusion 2006;46:53S-58S.
44Murphy, Scott.The case for a new approach for documenting platelet viability.Transfusion 2006;46:49S-52S.
43Aubuchon James P, Snyder Edward L.The rationale for a standardized approach to assessment of platelet kinetics.Transfusion 2006;46:44S-48S.
42TRANSFUSION SUPPLEMENT NOVEMBER 2006.Assessment of Platelet Recovery and Survival by Radiolabeling (Publication numbers 42-47 inclusive) Dedication in Memorium.Transfusion 2006;46:43S.
41Takahashi T, P Rebulla, S Armitage, J van Beckhoven, H Eichler, R. Kekomaki, M. Letowska, F Wahab and G. Moroff for the Biomedical Excellence for Safer Transfusion Collaborative.Multi-laboratory evaluation of procedures for reducing the volume of cord blood: influence on cell recoveries.Cytotherapy 2006; 8: 254-264.
40Heddle NM, Cook RJ, Sigouin C, Slichter SJ, Murphy M, Rebulla P in collaboration with the BEST Collaborative.A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia.Transfusion 2006;46:903-11.
39Moroff G, Eichler H, Brand A, Kekomaki R, Kurtz J, Letowska M, Pamphilon D, Read EJ, Porretti L, Lecchi L, Reems J-A, Sacher R, Seetharaman A, Takahashi TA for the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Multiple-laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood.Transfusion 2006;46:507-15.
38Dumont LJ, AuBuchon JP, Gulliksson H, Slichter SJ, Elfath MD, Holme S, Murphy JR, Rose LE, Popovsky MA, Murphy S.In vitro pH effects on in vivo recovery and survival of platelets - an analysis by the BEST Collaborative.Transfusion 2006;46:1300-5.
37Hess JR, Kagen LR, van der Meer PF, Simon T, Cardigan R, Greenwalt TJ, AuBuchon JP, Brand A, Lockwood W, Zanella A, Adamson J, Snyder E, Taylor HL, Moroff G, Hogman C.Interlaboratory comparison of red-cell ATP, 2,3-diphosphoglycerate and haemolysis measurements.Vox Sanguinis 2005;89:44-8.
36AuBuchon JP, Herschel L, Roger J, Dumont L, Murphy S, Slichter SJ, Whitley P, Snyder E, Goodrich RP.Comparison of computerized formulae for determination of platelet recovery and survival.Transfusion 2005;45:1237-8.
35Van der Meer PF, Gulliksson H, AuBuchon JP, Prowse C, de Wildt-Eggen J for the BEST Collaborative.Interruption of agitation of platelet concentrates: effects on in vitro parameters.Vox Sanguinis 2005;88:227-34.
34S Murphy for the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Platelets from pooled buffy coats: an update.Transfusion 2005;35:634-9.
33Eichler H, Seetharaman S, Latta M, Kurtz JW, Moroff G for the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.Comparison of total nucleated cell measurements of UC blood samples using two hematology analyzers.Cytotherapy, 6(5):457-464, 2004.
32PF van der Meer, H Gulliksson, JP AuBuchon, C Prowse, E Richter, J de Wildt-Eggen.Effect of interruption of agitation on in vitro quality of platelet concentrates.Transfusion 2004;44:69A.#
31Cook RJ, Heddle NM, Rebulla P, Sigouin CS and Webert KE in collaboration with BEST.Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers.Transfusion 2004;44:1135-42.
30T VandenBroeke, LJ Dumont, S Hunter, J Nixon, S Murphy, J Roger, L Herschel, JP AuBuchon, H Gulliksson, T Dengler, V Hornsey and C Prowse for BEST.Platelet storage solution effects on the accuracy of laboratory tests for platelet function: a multi-laboratory study.Vox Sanguinis 2004;86:183-8.
29Heddle NM, AuBuchon J, Barty RL, Brand A, Cook RJ, Murphy M, Rebulla P, Sigouin C for the BEST Working Party. Success in achieving a targeted platelet dose: What dose are we actually giving?Transfusion 2003;43:30-1A.#
28Beckman N, Sher G, Masse M, Richter E, Ringwald J, Rebulla P, van der Meer P, Justica B, Walker B, Rowe G, on behalf of the BEST Working Party of the ISBT.Review of the quality monitoring methods used by countries using or implementing universal leukoreduction.Transf Med Rev 2004;18:25-35.
27WH Dzik, MF Murphy, G Andreu, MD, N Heddle, C Hogman, R Kekomaki, S Murphy, M Shimizu, C Smit-Sibinga and the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society for Blood Transfusion.An international study of the performance of patient sample collection.Vox Sanguinis 2003;85:40-47.
26Heddle NM, Cook RJ, Webert KE, Sigouin C, Rebulla P, BEST Working Party.Methodological Issues in the Use of Bleeding as an Outcome in Transfusion Medicine Studies.Transfusion 2003;43:742-52.
25Dzik WH, Murphy MF, BEST Working Party, International Society of Blood Transfusion.An international study of the performance of patient sample collection.Transfusion 2002;42:26S.#
24VandenBroeke TL, Dumont LJ, Hunter S, Nixon J, Murphy S, Roger J, Herschel L, AuBuchon J, Gulliksson H, Dengler T, Hornsey V, Prowse C, for the Biomedical Excellence for Safer Transfusion Working Party.Platelet storage solution effects on the accuracy of laboratory tests for platelet function ñ a multilaboratory study.Transfusion 2002;42:53-S-54S.#
23Cardigan R, Sutherland J, Wadhwa M, Dilger P, Thorpe R.The influence of platelet additive solutions on cytokine levels and complement acticatiion in platelet concentrates during storage.Vox Sanguinis 2003;84:28-35.
22Gulliksson H, AuBuchon JP, Cardigan R, van der Meer PF, Murphy S, Prowse C, Richter E, Ringwald J, Smacchia A, Slichter S, de Wildt-Eggen J, for the Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion.A multicentre study of the in vitro effects of potassium and magnesium.Vox Sanguinis 2003;85:199-205.
21Gulliksson H, AuBuchon JP, Veserinen M, et al for the BEST Working Party of the ISBT.Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium.Vox Sanguinis 2002;82:131-136.
20Moroff G, Sowemimo-Coker SO, Finch S, Murphy S, Brandwein H, Whitbread J, Wenz B for the BEST Collaborative.The influence of various hematology analyzers on component platelet counts.Transf Med Rev 2005;19:155-66.
19Dzik S, Moroff G, Dumont L for the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the ISBT.A multicenter study evaluating three methods for counting residual WBCs in WBC-reduced blood components: Nageotte hemocytometry, flow cytometry, and microfluorometry.Transfusion, 2000,40:513-520.
18Dzik WH, Sniecinski I, Fisher J and the Biomedical Excellence for Safer Transfusion Working Party.Towards standardization of CD34+ cell enumeration: an international study.Transfusion, 1999;39:856-863.
17Adams MR, Fisher DM, Dumont LJ, Dzik WH, Heaton WA.Detecting failed WBC-reduction process on computer simulations of intermittent and continuous process failure.Transfusion, 2000;40:1427-1433.
16Dumont LJ, VandenBroeke T, Ault KA and the BEST Working Party of the International Society of Blood Transfusion.Platelet surface P-selectin measurements in platelet preparation: An International Collaborative Study.Transfus Med Rev 1999;13:31-42.#
15Moroff G, Brandwein H, Coker SO, Wenz B, For the Biomedical Excellence for Safer Transfusion (BEST) Working Party, International Society for Blood Transfusion.Counting platelets in simulated component samples with hematology analyzers. XXV Congress of the International Society of Blood Transfusion, Oslo, 1998.Vox Sang 1998:74(S1):1259.#
14Holme S, Moroff G, and Murphy S for the BEST Working Party of the International Society of Blood Transfusion.A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock.Transfusion 1998;38:31-40.
13Heaton WAL, Rebulla P, Pappalettera M, Dzik WH for the BEST Working Party of the International Society of Blood Transfusion.A comparative analysis of different methods for routine blood component preparation.Transfusion Medicine Reviews, 1997;2:116-129.#
12Murphy S, Heaton WAL, Rebulla P and the BEST Working Party of the International Society of Blood Transfusion.Platelet production in the Old World - and the New.Transfusion 1996;36:751-754.#
11Prati D, Brandwein H, Capelli C, Dzik WH, Masse M, Myllylä G, Stromberg RR, Takahashi T, Vyas GN, Wenz B.Multicenter evaluation of the 3% PFA method for white cell counting in leukocyte-reduced red blood cells.Vox Sanguinis 1996;70:241-245.
10Dumont LJ, Dzik WH, Rebulla P, Brandwein H and the members of the Biomedical Excellence for Safer Transfusion (BEST) Committee of the ISBT.Practical guidelines for process control and validation of leukoreduced components: report of the BEST Working Party of the ISBT.Transfusion 1996;36:11-20.
9Bertolini F, Murphy S for the BEST Working Party of the International Society of Blood Transfusion.A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice.Transfusion 1996;36:128-132.
8Sirchia G.The Best Working Party of the International Society of Blood Transfusion: an international effort to improve the quality of blood components.Transfusion 1995;35:254-257.
7Heaton WAL for the BEST Working Party of the ISBT.Multicenter evaluation of the methods of preparation of routine platelet concentrates (abstract).Transfusion 1994;34(Suppl):12S.#
6Heaton WAL for the BEST Working Party of the ISBT.Multicenter evaluation of preparation of buffy-coat poor red blood cells (abstract).Transfusion 1994;34(Suppl):7S.#
5Murphy S, Rebulla P, Bertolini F, Holme S, Moroff G, Snyder E, Stromberg RR for the BEST (Biomedical Excellence for Safer Transfusion) Task Force of the ISBT.In vitro assessment of the quality of stored platelet concentrates.Transfus Med Rev 1994;8:29-36.
4Bertolini F, Murphy S.A multicenter evaluation of reproducibility of swirling in platelet concentrates. The Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion.Transfusion 1994;34:796-801.
3Rebulla P, Dzik WH.Multicenter evaluation of methods for counting residual white cells in leukocyte-depleted red blood cells.Vox Sanguinis 1994;66:25-32.
2Murphy S, Bertolini F.Assessment of swirling and percent discs by oil, phase microscopy as quality control procedures for platelet concentrates (abstract).Transfusion 1993;33(Suppl):10S#
1Vyas GN.Evaluation of Nageotte chamber and flow cytometry for WBC count in WBC-reduced RBC (abstract).Transfusion 1992;32(Suppl):76S.